SiteOne Therapeutics's competitors

SiteOne Therapeutics's competitors include Relay Therapeutics, Biohaven Pharmaceutical, Enanta Pharmaceuticals and CEL-SCI
Add company...
SiteOne Therapeutics
SiteOne Therapeutics is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids
Relay Therapeutics
Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.
Biohaven Pharmaceutical
Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.
Enanta Pharmaceuticals
Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Founding Date
Founding Date
2010
Founding Date
2016
Founding Date
2014
Founding Date
1998
Founding Date
1983
Type
Type
Private
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Bozeman, US HQ
Locations
Cambridge, US HQ
Locations
New Haven, US HQ
Locations
Watertown, US HQ
Locations
Vienna, US HQ
Employees
Employees
N/A
Employees
592% increase
Employees
484% increase
Employees
8917% increase
Employees
43
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
2 b
Valuation ($)
47.3 m

Financial

Net income
Net income
N/A
Net income
N/A
Net income
N/A
Net income
$17.7m (FY, 2017)
Net income
($14.4m) (FY, 2017)

Funding

Latest funding round
Latest funding round
$ 15m (over 1 year ago)
Latest funding round
$ 63m (5 months ago)
Latest funding round
$ 80m (over 1 year ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 17.8m
Total funding raised
$ 120m
Total funding raised
$ 80m
Total funding raised
$ 9.2m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Relay Therapeutics
HQ
Cambridge, US
Employees
59↑ 2% increase

Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.

View company
Biohaven Pharmaceutical
HQ
New Haven, US
Employees
48↑ 4% increase

Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.

View company
Enanta Pharmaceuticals
HQ
Watertown, US
Employees
89↑ 17% increase

Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs.

View company
CEL-SCI
HQ
Vienna, US
Employees
43

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

View company